Product Supply
This section is intended to provide information to healthcare professionals on any supply issues we are currently experiencing or any discontinuations. Please be reassured that MSD takes supply of its products very seriously and will be doing everything it can to mitigate any supply issues.
From time to time we may experience shortages of some products and may divest or discontinue others.
MSD UK customer services
(9am-5pm, Mon-Fri)
0208 1548001
(Out of normal working hours, during public holidays and weekends, please contact our UK switchboard on 0208 1548000).
PHARMACEUTICAL SUPPLY STATUS
| No out of stocks to report | ||
VACCINES SUPPLY STATUS
| Product Description | Supply Status | Estimated Resupply Date |
| GARDASIL® 9 (National Immunisation Programme) | N/A | Please refer to ImmForm for NIP supply status |
| GARDASIL® 9 | Full Supply | |
| VAQTA Paediatric | Full Supply | |
| VAQTA Adult | Full Supply | |
| HBVAXPRO 5mcg | Full Supply | |
| HBVAXPRO 10mcg | Full Supply | |
| HBVAXPRO 40mcg | Full Supply | |
| M-M-RVAXPRO (National Immunisation Programme) | N/A | Please refer to ImmForm for NIP supply status |
| M-M-RVAXPRO | Full Supply | |
| PNEUMOVAX 23 (pre-filled syringes) National Immunisation Programme | N/A | Please refer to ImmForm for NIP supply status |
| PNEUMOVAX 23 (pre-filled syringes) | Full Supply | |
| VAXNEUVANCE▼ ((pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed))) | Full Supply | |
| VARIVAX | Full Supply |
MSD Medicines and Vaccines can be ordered from:
Alliance Healthcare Customer Services
Telephone: 0330 100 0448
Email: customerservice@alliance-healthcare.co.uk
NOTIFICATIONS
Information about Simponi (golimumab) and Remicade (infliximab)
MSD UK no longer distributes Simponi and Remicade, effective 1st October 2024. Please contact Johnson & Johnson, JnJ_IMUKCS@its.jnj.com, 01494567400, for more information on how to access Simponi and Remicade.
Information about OncoTICE® (2-8 X 108 CFU Tice® BCG) powder for suspension
Due to increased global demand and as the primary supplier of OncoTICE®/(TICE® /BCG) in the UK, MSD has been experiencing supply constraints. To minimise disruption to patient care, available supply of OncoTICE®/(TICE® /BCG) is proportionally allocated across countries.
MSD are working with the Department of Health and Social Care (DHSC) and relevant professional organisations to ensure equitable distribution of the medicine across NHS.
British Association of Urological Surgeons (BAUS) guidance may be found here.
Alliance Healthcare Customer Services
Telephone: 0330 100 0448
Information about MERCI Device
MSD UK no longer distributes MERCI device, effective 10th June 2024. Please contact Alliance Healthcare, customerservice@alliance-healthcare.co.uk, for more information on how to access MERCI device.
DISCONTINUATIONS
Product Description
Primaxin IV 500mg/500mg powder for infusion
Esmeron 10mg/ml solution for injection
Cancidas 50mg powder for concentrate for solution for infusion
This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck & Co., Inc., Rahway, NJ, USA, its subsidiaries or affiliates, except as noted.
Job code: GB-NON-10415 | Date of preparation: November 2024